StemLift, a trademarked procedure developed by Mr Hazim Sadideen, is a regenerative approach to breast enhancement that combines advanced fat grafting techniques with the natural regenerative properties of the harvested tissue. Fat is carefully removed from a donor site on the patient’s own body, processed to concentrate the regenerative cellular components, and then precisely transferred to the breast to restore volume, improve contour and enhance skin quality.
Unlike implant-based augmentation, StemLift introduces no foreign material into the body. The transferred tissue integrates naturally with the existing breast tissue, producing a result that looks, feels and behaves like the patient’s own, with the additional benefit of modest contouring at the donor site. StemLift is suitable for patients seeking a natural increase in breast volume, improvement in breast shape or symmetry, enhancement following pregnancy or weight loss, or a subtle lift without the commitment of implants or surgical mastopexy.
StemLift is not simply fat injection. It is a considered surgical procedure that requires precise anatomical planning, careful harvest and processing of the donor tissue, and meticulous placement to ensure graft survival and a natural result.
StemLift is designed for patients who are seeking natural breast enhancement without implants and want to restore volume lost through pregnancy, breastfeeding or weight loss. It suits those wishing to improve breast shape, symmetry or contour rather than achieve a significant increase in size, who have sufficient donor fat available for harvest at an appropriate site, and who are at a stable, healthy weight and not planning significant weight loss after the procedure. Good candidates are in good general health, free from conditions that could impair healing or graft survival, are non-smokers, or committed to stopping well in advance of surgery, and have realistic expectations about the degree of enhancement achievable with fat transfer.
StemLift is not suitable for patients seeking a substantial increase in breast size, as the volume achievable is limited by the available donor tissue and the capacity of the recipient site. For patients seeking more significant augmentation, Mr Sadideen will discuss whether a hybrid approach combining fat transfer with a small implant may be appropriate.
Mr Hazim Sadideen is a board-certified and FRCS-qualified consultant plastic surgeon specialising in aesthetic, reconstructive and regenerative plastic surgery. His approach is grounded in clinical evidence, meticulous surgical technique and personalised planning.
Patients choose Mr Sadideen for his:
Recovery following StemLift involves two treated areas: the breast and the donor site. Patients can generally expect a day-case procedure in most cases, returning home the same day, with mild to moderate swelling, bruising and tenderness at both sites for one to two weeks. A supportive surgical bra is worn for six to eight weeks, alongside a compression garment at the donor site worn for four to six weeks. Most patients return to desk-based work at one to two weeks, avoiding strenuous exercise for six weeks. Manual lymphatic drainage is recommended post-operatively at both sites, and Mr Sadideen integrates clinical nutrition and functional medicine principles into the recovery plan to optimise graft survival and support long-term tissue quality.
StemLift integrates naturally into a broader surgical or non-surgical treatment plan. For patients who want more volume than fat transfer alone can reliably achieve, combining StemLift with a small implant, known as hybrid augmentation, produces a result that is softer and more natural than implants alone, with the added benefit of improved upper pole coverage and skin quality. Where ptosis is present alongside volume loss, combining StemLift with a surgical breast lift (mastopexy) addresses both concerns in a single procedure. Because fat harvest is performed using liposuction technique, patients also benefit from simultaneous contouring at the donor site. For patients who ultimately decide that implants are the right choice, Mr Sadideen’s SlimBreast programme offers the same anatomy-led, natural-results philosophy with implant-based augmentation.
Once the transferred fat has integrated and stabilised, typically over three to six months, the results are permanent. Maintaining a stable weight after the procedure supports the longevity of the outcome, as significant weight fluctuation can affect the volume of the transferred fat.
StemLift is a surgical procedure and carries inherent risks that are discussed openly during consultation, including:
Mr Sadideen’s thorough preoperative assessment, precise fat processing and placement technique, and structured aftercare programme are all designed to maximise graft survival and minimise the risk of complications.
For the Latest Updates of Mr Hazim Sadideen
